Available online at: (Accessed 28, October, 2025)
e.g., vorinostat, romidepsin), and bromodomain and extraterminal domain (BET) inhibitors (e.g., JQ1), can reverse the silencing of tumor suppressor genes, suppress oncogenic transcriptional programs, and resensitize tumors to chemotherapy, targeted agents, or immunotherapy
When side effects occur, many users report that symptoms are temporary and resolve after treatment adjustments or discontinuation
It plays integral roles in: Immune regulation Cancer suppression (anti-proliferative and pro-apoptotic signaling) Mitochondrial function and redox balance Hormonal feedback loops, including cortisol and estrogen/testosterone rhythms Aging diminishes melatonin output by up to 75%, leading to weaker circadian cues and downstream systemic dysfunction